abstract |
The present invention relates to a compound of formula I which inhibits the activity of an anti-apoptotic Bcl-2 or Bcl-X L protein, a composition containing said compound, and a method of treating a disease in which an anti-apoptotic Bcl-2 protein is expressed do. Formula I |